Change in the cortical complexity of spinocerebellar ataxia type 3 appears earlier than clinical symptoms

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Wang, Tzu Yun ^a   Jao, Chii Wen ^a,b   Soong, Bing Wen ^a,c   Wu, Hsiu Mei ^c   Shyu, Kuo Kai ^d   Wang, Po Shan ^a,c,e   Wu, Yu Te ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b Asia Pacific Institute of Creativity   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL CENTRAL UNIVERSITY   (Taiwan)

^e TAIPEI MUNICIPAL GAN DAU HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN CORTEX; BRAIN CORTEX ATROPHY; BRAIN DYSFUNCTION; BRAIN REGION; CEREBELLUM ATROPHY; CEREBELLUM CORTEX; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; ELECTROENCEPHALOGRAPHY; FEMALE; FRACTAL ANALYSIS; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; RATING SCALE; SCALE FOR THE ASSESSMENT AND RATING OF ATAXIA; SPINOCEREBELLAR ATAXIA TYPE 3; SPINOCEREBELLAR DEGENERATION; SYMPTOMATOLOGY; THREE DIMENSIONAL IMAGING; CASE CONTROL STUDY; CEREBELLAR ATAXIA; COMPARATIVE STUDY; MACHADO JOSEPH DISEASE; MIDDLE AGED; PATHOLOGY; PROCEDURES;

CASE-CONTROL STUDIES; CEREBELLAR ATAXIA; CEREBRAL CORTEX; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MACHADO-JOSEPH DISEASE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 84928473372     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118828     Document Type: Article

References (80)

1. Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, Katayama S, et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nature genetics. 1994; 8(3):221-8. Epub 1994/11/01. doi: 10.1038/ng1194-221 PMID: 7874163.
2. Riess O, Rub U, Pastore A, Bauer P, Schols L. SCA3: neurological features, pathogenesis and animal models. Cerebellum. 2008; 7(2):125-37. Epub 2008/04/18. doi: 10.1007/s12311-008-0013-4 PMID: 18418689.
3. Roeske S, Filla I, Heim S, Amunts K, Helmstaedter C, Wullner U, et al. Progressive cognitive dysfunction in spinocerebellar ataxia type 3. Movement disorders: official journal of the Movement Disorder Society. 2013; 28(10):1435-8. doi: 10.1002/mds.25512 PMID: 23736996.
4. Zawacki TM, Grace J, Friedman JH, Sudarsky L. Executive and emotional dysfunction in Machado-Joseph disease. Movement disorders: official journal of the Movement Disorder Society. 2002; 17 (5):1004-10. Epub 2002/10/03. doi: 10.1002/mds.10033 PMID: 12360550.
5. Klinke I, Minnerop M, Schmitz-Hübsch T, Hendriks M, Klockgether T, Wüllner U, et al. Neuropsychological features of patients with spinocerebellar ataxia (SCA) types 1, 2, 3, and 6. The Cerebellum. 2010; 9 (3):433-42. doi: 10.1007/s12311-010-0183-8 PMID: 20502998
6. Kawai Y, Takeda A, Abe Y, Washimi Y, Tanaka F, Sobue G. Cognitive impairments in machado-joseph disease. Archives of neurology. 2004; 61(11):1757-60. doi: 10.1001/archneur.61.11.1757 PMID: 15534186
7. Yamada M, Tan CF, Inenaga C, Tsuji S, Takahashi H. Sharing of polyglutamine localization by the neuronal nucleus and cytoplasm in CAG-repeat diseases. Neuropathology and applied neurobiology. 2004; 30(6):665-75. doi: 10.1111/j.1365-2990.2004.00583.x PMID: 15541006.
8. Yamada M, Hayashi S, Tsuji S, Takahashi H. Involvement of the cerebral cortex and autonomic ganglia in Machado-Joseph disease. Acta neuropathologica. 2001; 101(2):140-4. Epub 2001/03/29. PMID: 11271368.
9. Seidel K, den Dunnen WF, Schultz C, Paulson H, Frank S, de Vos RA, et al. Axonal inclusions in spinocerebellar ataxia type 3. Acta neuropathologica. 2010; 120(4):449-60. Epub 2010/07/17. doi: 10.1007/s00401-010-0717-7 PMID: 20635090; PubMed Central PMCID: PMC2923324.
10. Soong BW, Liu RS. Positron emission tomography in asymptomatic gene carriers of Machado-Joseph disease. Journal of neurology, neurosurgery, and psychiatry. 1998; 64(4):499-504. Epub 1998/05/12. PMID: 9576542; PubMed Central PMCID: PMC2170028.
11. Wullner U, Reimold M, Abele M, Burk K, Minnerop M, Dohmen BM, et al. Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6. Archives of neurology. 2005; 62 (8):1280-5. Epub 2005/08/10. doi: 10.1001/archneur.62.8.1280 PMID: 16087769.
12. Yamada M, Sato T, Tsuji S, Takahashi H. CAG repeat disorder models and human neuropathology: similarities and differences. Acta neuropathologica. 2008; 115(1):71-86. Epub 2007/09/06. doi: 10.1007/s00401-007-0287-5 PMID: 17786457.
13. Murata Y, Yamaguchi S, Kawakami H, Imon Y, Maruyama H, Sakai T, et al. Characteristic magnetic resonance imaging findings in Machado-Joseph disease. Archives of neurology. 1998; 55(1):33. PMID: 9443709
14. Goel G, Pal PK, Ravishankar S, Venkatasubramanian G, Jayakumar PN, Krishna N, et al. Gray matter volume deficits in spinocerebellar ataxia: An optimized voxel based morphometric study. Parkinsonism & related disorders. 2011; 17(7):521-7. doi: 10.1016/j.parkreldis.2011.04.008
15. Lopes TM, D'Abreu A, Junior MCF, Yasuda CL, Betting LE, Samara AB, et al. Widespread neuronal damage and cognitive dysfunction in spinocerebellar ataxia type 3. Journal of neurology. 2013; 260 (9):2370-9. doi: 10.1007/s00415-013-6998-8 PMID: 23775343
16. Reetz K, Costa AS, Mirzazade S, Lehmann A, Juzek A, Rakowicz M, et al. Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6. Brain: a journal of neurology. 2013; 136(Pt 3):905-17. doi: 10.1093/brain/aws369 PMID: 23423669.
17. Braga-Neto P, Dutra LA, Pedroso JL, Barsottini OGP. Cognitive dysfunction in spinocerebellar ataxia type 3: Variable topographies and patterns. Movement Disorders. 2014; 29(1):156-7. doi: 10.1002/mds.25756 PMID: 24338620
18. Roeske S, Filla I, Heim S, Amunts K, Helmstaedter C, Wüllner U, et al. Reply to: Cognitive dysfunction in spinocerebellar ataxia type 3: Variable topographies and patterns. Movement Disorders. 2014; 29 (1):157-8. doi: 10.1002/mds.25755 PMID: 24338591
19. Hu H-H, Chen H-Y, Hung C-I, Guo W-Y, Wu Y-T. Shape and curvedness analysis of brain morphology using human fetal magnetic resonance images in utero. Brain Structure and Function. 2013; 218 (6):1451-62. doi: 10.1007/s00429-012-0469-3 PMID: 23135358
20. Zilles K, Armstrong E, Schleicher A, Kretschmann H-J. The human pattern of gyrification in the cerebral cortex. Anatomy and embryology. 1988; 179(2):173-9. PMID: 3232854
21. Wu YT, Shyu KK, Jao CW, Wang ZY, Soong BW, Wu HM, et al. Fractal dimension analysis for quantifying cerebellar morphological change of multiple system atrophy of the cerebellar type (MSA-C). Neuro-Image. 2010; 49(1):539-51. Epub 2009/07/29. doi: 10.1016/j.neuroimage.2009.07.042 PMID: 19635573.
22. Wu Y.-T., Shyu K.-K., Chen T.-R., Guo W.-Y. Using three-dimensional fractal dimension to analyze the complexity of fetal cortical surface from magnetic resonance images. Nonlinear Dynamics. 2009; 58 (4):745-752
23. Wu Y-T, Shyu K-K, Jao C-W, Liao Y-L, Wang T-Y, Wu H-M, et al. Quantifying cerebellar atrophy in multiple system atrophy of the cerebellar type (MSA-C) using three-dimensional gyrification index analysis. NeuroImage. 2012; 61(1):1-9. doi: 10.1016/j.neuroimage.2012.02.057 PMID: 22401757
24. Zhang L, Butler AJ, Sun CK, Sahgal V, Wittenberg GF, Yue GH. Fractal dimension assessment of brain white matter structural complexity post stroke in relation to upper-extremity motor function. Brain research. 2008; 1228:229-40. Epub 2008/07/02. doi: 10.1016/j.brainres.2008.06.008 PMID: 18590710; PubMed Central PMCID: PMC2655112.
25. Zhang L, Dean D, Liu JZ, Sahgal V, Wang X, Yue GH. Quantifying degeneration of white matter in normal aging using fractal dimension. Neurobiology of aging. 2007; 28(10):1543-55. Epub 2006/07/25. doi: 10.1016/j.neurobiolaging.2006.06.020 PMID: 16860905.
26. Zhang L, Liu JZ, Dean D, Sahgal V, Yue GH. A three-dimensional fractal analysis method for quantifying white matter structure in human brain. Journal of neuroscience methods. 2006; 150(2):242-53. Epub 2005/08/23. doi: 10.1016/j.jneumeth.2005.06.021 PMID: 16112737.
27. King RD, George AT, Jeon T, Hynan LS, Youn TS, Kennedy DN, et al. Characterization of Atrophic Changes in the Cerebral Cortex Using Fractal Dimensional Analysis. Brain imaging and behavior. 2009; 3(2):154-66. Epub 2009/06/01. doi: 10.1007/s11682-008-9057-9 PMID: 20740072; PubMed Central PMCID: PMC2927230.
28. Pereira JB, Ibarretxe-Bilbao N, Marti MJ, Compta Y, Junqué C, Bargallo N, et al. Assessment of cortical degeneration in patients with Parkinson's disease by voxel - based morphometry, cortical folding, and cortical thickness. Human brain mapping. 2012; 33(11):2521-34. doi: 10.1002/hbm.21378 PMID: 21898679
29. Di Ieva A, Esteban FJ, Grizzi F, Klonowski W, Martin-Landrove M. Fractals in the Neurosciences, Part II: Clinical Applications and Future Perspectives. The Neuroscientist: a review journal bringing neurobiology, neurology and psychiatry. 2013. doi: 10.1177/1073858413513928 PMID: 24362814.
30. Esteban FJ, Sepulcre J, de Miras JR, Navas J, de Mendizábal NV, Goñi J, et al. Fractal dimension analysis of grey matter in multiple sclerosis. Journal of the neurological sciences. 2009; 282(1):67-71.
31. King RD, Brown B, Hwang M, Jeon T, George AT. Fractal dimension analysis of the cortical ribbon in mild Alzheimer's disease. NeuroImage. 2010; 53(2):471-9. doi: 10.1016/j.neuroimage.2010.06.050 PMID: 20600974
32. Sandu A-L, Rasmussen I-A Jr, Lundervold A, Kreuder F, Neckelmann G, Hugdahl K, et al. Fractal dimension analysis of MR images reveals grey matter structure irregularities in schizophrenia. Computerized medical imaging and graphics: the official journal of the Computerized Medical Imaging Society. 2008; 32(2):150-8. Epub 2007/12/11. doi: 10.1016/j.compmedimag.2007.10.005 PMID: 18068333.
33. Ha TH, Yoon U, Lee KJ, Shin YW, Lee JM, Kim IY, et al. Fractal dimension of cerebral cortical surface in schizophrenia and obsessive-compulsive disorder. Neuroscience letters. 2005; 384(1-2):172-6. Epub 2005/05/17. doi: 10.1016/j.neulet.2005.04.078 PMID: 15893428.
34. Li X, Jiang J, Zhu W, Yu C, Sui M, Wang Y, et al. Asymmetry of prefrontal cortical convolution complexity in males with attention-deficit/hyperactivity disorder using fractal information dimension. Brain & development. 2007; 29(10):649-55. Epub 2007/06/19. doi: 10.1016/j.braindev.2007.04.008 PMID: 17573219.
35. Sandu AL, Paillere Martinot ML, Artiges E, Martinot JL. 1910s' brains revisited. Cortical complexity in early 20th century patients with intellectual disability or with dementia praecox. Acta psychiatrica Scandinavica. 2014. doi: 10.1111/acps.12243 PMID: 24400850.
36. Yang JJ, Yoon U, Yun HJ, Im K, Choi YY, Lee KH, et al. Prediction for human intelligence using morphometric characteristics of cortical surface: partial least square analysis. Neuroscience. 2013; 246:351-61. doi: 10.1016/j.neuroscience.2013.04.051 PMID: 23643979.
37. Mustafa N, Ahearn TS, Waiter GD, Murray AD, Whalley LJ, Staff RT. Brain structural complexity and life course cognitive change. NeuroImage. 2012; 61(3):694-701. doi: 10.1016/j.neuroimage.2012.03.088 PMID: 22510257.
38. Im K, Lee JM, Yoon U, Shin YW, Hong SB, Kim IY, et al. Fractal dimension in human cortical surface: Multiple regression analysis with cortical thickness, sulcal depth, and folding area. Human brain mapping. 2006; 27(12):994-1003. PMID: 16671080
39. Schmitz-Hübsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, et al. Scale for the assessment and rating of ataxia Development of a new clinical scale. Neurology. 2006; 66(11):1717-20. PMID: 16769946
40. Schmitz-Hubsch T, Tezenas du Montcel S, Baliko L, Boesch S, Bonato S, Fancellu R, et al. Reliability and validity of the International Cooperative Ataxia Rating Scale: a study in 156 spinocerebellar ataxia patients. Movement disorders. 2006; 21(5):699-704. doi: 10.1002/mds.20781 PMID: 16450347.
41. Jacobi H, Bauer P, Giunti P, Labrum R, Sweeney M, Charles P, et al. The natural history of spinocerebellar ataxia type 1, 2, 3, and 6 A 2-year follow-up study. Neurology. 2011; 77(11):1035-41. doi: 10.1212/WNL.0b013e31822e7ca0 PMID: 21832228
42. D'Abreu A, Franca MC Jr, Yasuda CL, Campos BA, Lopes-Cendes I, Cendes F. Neocortical atrophy in machado-joseph disease: a longitudinal neuroimaging study. Journal of neuroimaging: official journal of the American Society of Neuroimaging. 2012; 22(3):285-91. Epub 2011/06/28. doi: 10.1111/j.1552-6569.2011.00614.x PMID: 21699609.
43. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology. 1998; 50(2):318-. PMID: 9484345
44. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. Journal of psychiatric research. 1975; 12(3):189-98. PMID: 1202204
45. Woods RP, Grafton ST, Holmes CJ, Cherry SR, Mazziotta JC. Automated image registration: I. General methods and intrasubject, intramodality validation. Journal of computer assisted tomography. 1998; 22 (1):139-52. PMID: 9448779
46. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage. 2002; 15(1):273-89. Epub 2002/01/05. doi: 10.1006/nimg.2001.0978 PMID: 11771995.
47. Mandelbrot BB. Fractals: Form, Chance and Dimension. Freeman, San Francisco, 1977: 365 p.
48. Esteban FJ, Sepulcre J, de Mendizabal NV, Goni J, Navas J, de Miras JR, et al. Fractal dimension and white matter changes in multiple sclerosis. NeuroImage. 2007; 36(3):543-9. Epub 2007/05/15. doi: 10.1016/j.neuroimage.2007.03.057 PMID: 17499522.
49. Jarque CM, Bera AK. Efficient tests for normality, homoscedasticity and serial independence of regression residuals. Economics Letters. 1980; 6(3):255-9.
50. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B (Methodological). 1995; 57:289-300.
51. Rub U, de Vos RA, Brunt ER, Sebesteny T, Schols L, Auburger G, et al. Spinocerebellar ataxia type 3 (SCA3): thalamic neurodegeneration occurs independently from thalamic ataxin-3 immunopositive neuronal intranuclear inclusions. Brain Pathol. 2006; 16(3):218-27. Epub 2006/08/17. doi: 10.1111/j.1750-3639.2006.00022.x PMID: 16911479.
52. Burk K, Abele M, Fetter M, Dichgans J, Skalej M, Laccone F, et al. Autosomal dominant cerebellar ataxia type I clinical features and MRI in families with SCA1, SCA2 and SCA3. Brain: a journal of neurology. 1996; 119:1497-505. Epub 1996/10/01. PMID: 8931575.
53. Klockgether T, Skalej M, Wedekind D, Luft AR, Welte D, Schulz JB, et al. Autosomal dominant cerebellar ataxia type I. MRI-based volumetry of posterior fossa structures and basal ganglia in spinocerebellar ataxia types 1, 2 and 3. Brain: a journal of neurology. 1998; 121 (Pt 9):1687-93. Epub 1998/10/08.PMID: 9762957.
54. Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain: a journal of neurology. 1998; 121 (Pt 4)(4):561-79. Epub 1998/05/13. PMID: 9577385.
55. Schmahmann JD, Caplan D. Cognition, emotion and the cerebellum. Brain: a journal of neurology. 2006; 129(2):290-2. PMID: 16434422
56. Schmahmann JD. Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. The Journal of neuropsychiatry and clinical neurosciences. 2004; 16 (3):367-78. PMID: 15377747
57. Jacobi H, Hauser T-K, Giunti P, Globas C, Bauer P, Schmitz-Hübsch T, et al. Spinocerebellar Ataxia Types 1, 2, 3 and 6: the Clinical Spectrum of Ataxia and Morphometric Brainstem and Cerebellar Findings. The Cerebellum. 2012; 11(1):155-66. doi: 10.1007/s12311-011-0292-z PMID: 21701895
58. Scherzed W, Brunt E, Heinsen H, de Vos R, Seidel K, Bürk K, et al. Pathoanatomy of cerebellar degeneration in spinocerebellar ataxia type 2 (SCA2) and type 3 (SCA3). The Cerebellum. 2012; 11 (3):749-60. doi: 10.1007/s12311-011-0340-8 PMID: 22198871
59. Takiyama Y, Oyanagi S, Kawashima S, Sakamoto H, Saito K, Yoshida M, et al. A clinical and pathologic study of a large Japanese family with Machado-Joseph disease tightly linked to the DNA markers on chromosome 14q. Neurology. 1994; 44(7):1302-. PMID: 8035935
60. Schulz JB, Borkert J, Wolf S, Schmitz-Hubsch T, Rakowicz M, Mariotti C, et al. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6. NeuroImage. 2010; 49(1):158-68. Epub 2009/07/28. doi: 10.1016/j.neuroimage.2009.07.027 PMID: 19631275.
61. Middleton FA, Strick PL. Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain research reviews. 2000; 31(2-3):236-50. doi: 10.1016/S0165-0173(99)00040-5 PMID: 10719165
62. Rub U, Seidel K, Ozerden I, Gierga K, Brunt ER, Schols L, et al. Consistent affection of the central somatosensory system in spinocerebellar ataxia type 2 and type 3 and its significance for clinical symptoms and rehabilitative therapy. Brain research reviews. 2007; 53(2):235-49. Epub 2006/10/04. doi: 10.1016/j.brainresrev.2006.08.003 PMID: 17014911.
63. Andreasen NC, O'Leary DS, Arndt S, Cizadlo T, Hurtig R, Rezai K, et al. Short-term and long-term verbal memory: a positron emission tomography study. Proceedings of the National Academy of Sciences. 1995; 92(11):5111-5. PMID: 7761457
64. Barbas H. Anatomic basis of cognitive-emotional interactions in the primate prefrontal cortex. Neuroscience & Biobehavioral Reviews. 1995; 19(3):499-510.
65. Epstein R, Kanwisher N. A cortical representation of the local visual environment. Nature. 1998; 392 (6676):598-601. PMID: 9560155
66. Kastner S, Ungerleider LG. Mechanisms of visual attention in the human cortex. Annual review of neuroscience. 2000; 23(1):315-41.
67. Fuster JM. Executive frontal functions. Experimental Brain Research. 2000; 133(1):66-70. PMID: 10933211
68. Radvany J, Camargo C, Costa Z, Fonseca N, Nascimento E. Machado-Joseph disease op azorean ancestry in Brazil: the Catarina kindred neurological, neuroimaging, psychiatric and neuropsychological findings in the largest known family, the "Catarina" kindred. Arquivos de neuro-psiquiatria. 1993; 51(1):21-30. PMID: 8215926
69. Ishikawa A, Yamada M, Makino K, Aida I, Idezuka J, Ikeuchi T, et al. Dementia and delirium in 4 patients with Machado-Joseph disease. Archives of neurology. 2002; 59(11):1804-8. Epub 2002/11/16. PMID: 12433269.
70. Buchsbaum MS, Escobar MD, Makuch RW, Nuechterlein KH, Guich SM. EEG coherence of prefrontal areas in normal and schizophrenic males during perceptual activation. Neurosciences. 1991; 3:169-75.
71. Abrams R, Taylor M. DIfferential eeg patterns in affective disorder and schizophrenia. Archives of General Psychiatry. 1979; 36(12):1355-8. doi: 10.1001/archpsyc.1979.01780120085010 PMID: 496554
72. Boutros NN, Arfken C, Galderisi S, Warrick J, Pratt G, Iacono W. The status of spectral EEG abnormality as a diagnostic test for schizophrenia. Schizophrenia research. 2008; 99(1-3):225-37. doi: 10.1016/j.schres.2007.11.020 PMID: 18160260; PubMed Central PMCID: PMC2288752.
73. Li Y, Tong S, Liu D, Gai Y, Wang X, Wang J, et al. Abnormal EEG complexity in patients with schizophrenia and depression. Clinical Neurophysiology. 2008; 119(6):1232-41. doi: 10.1016/j.clinph.2008.01.104 PMID: 18396454
74. Fukutani Y, Katsukawa K, Matsubara R, Kobayashi K, Nakamura I, Yamaguchi N. Delirium associated with Joseph disease. Journal of Neurology, Neurosurgery & Psychiatry. 1993; 56(11):1207-12.
75. Kaplan PW, Rossetti AO. EEG patterns and imaging correlations in encephalopathy: encephalopathy part II. Journal of Clinical Neurophysiology. 2011; 28(3):233-51. doi: 10.1097/WNP.0b013e31821c33a0 PMID: 21633250
76. Sutter R, Stevens RD, Kaplan PW. Clinical and imaging correlates of EEG patterns in hospitalized patients with encephalopathy. Journal of neurology. 2013; 260(4):1087-98. doi: 10.1007/s00415-012-6766-1 PMID: 23196336
77. Ghisolfi ES, Maegawa GHB, Becker J, Paula Zanardo A, Strimitzer IM Jr, Prokopiuk AS, et al. Impaired P50 sensory gating in Machado-Joseph disease. Clinical Neurophysiology. 2004; 115(10):2231-5. doi: 10.1016/j.clinph.2004.04.025 PMID: 15351363
78. Braga-Neto P, Felicio AC, Pedroso JL, Dutra LA, Bertolucci PH, Gabbai AA, et al. Clinical correlates of olfactory dysfunction in spinocerebellar ataxia type 3. Parkinsonism & related disorders. 2011; 17 (5):353-6. Epub 2011/03/04. doi: 10.1016/j.parkreldis.2011.02.004 PMID: 21367642.
79. Socal MP, Emmel VE, Rieder CRM, Hilbig A, Saraiva-Pereira ML, Jardim LB. Intrafamilial variability of Parkinson phenotype in SCAs: Novel cases due to SCA2 and SCA3 expansions. Parkinsonism & related disorders. 2009; 15(5):374-8. doi: 10.1016/j.parkreldis.2008.09.005
80. Pendlebury ST, Cuthbertson FC, Welch SJ, Mehta Z, Rothwell PM. Underestimation of cognitive impairment by mini-mental state examination versus the montreal cognitive assessment in patients with transient ischemic attack and stroke A population-based study. Stroke; a journal of cerebral circulation. 2010; 41(6):1290-3. doi: 10.1161/STROKEAHA.110.579888 PMID: 20378863